Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2005
03/10/2005WO2005020927A2 Method of promoting graft survival with anti-tissue factor antibodies
03/10/2005WO2005020923A2 Composition and method for the treatment of cancer and other physiologic conditions based on modulation of the ppar-gamma pathway and her-kinase axis
03/10/2005WO2005020919A2 Method of treatment and bioassay involving macrophage migration inhibitory factor (mif) as cardiac-derived myocardial depressant factor
03/10/2005WO2005020891A2 Monoclonal antibodies against ricin toxin and methods of making and using thereof
03/10/2005WO2005020889A2 Functional influenza virus-like particles (vlps)
03/10/2005WO2005020785A2 Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis
03/10/2005WO2004104033A3 Viruses dependent on inducing agents for viral entry into a host cell
03/10/2005WO2004098497A3 Cd4+ human papillomavirus (hpv) epitopes
03/10/2005WO2004078907A3 Streptococcus pyogenes antigens
03/10/2005WO2004075723A3 Methods for the early diagnosis of ovarian cancer
03/10/2005WO2004058808A3 Dna vaccines against hantavirus infections
03/10/2005WO2004058190A3 Methods for treating taxol-induced sensory neuropathy
03/10/2005WO2004056971A3 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
03/10/2005WO2004055161A3 Large scale production of packaged alphavirus replicons
03/10/2005WO2004030608A3 Nanoemulsion vaccines
03/10/2005WO2004003166A3 Antibodies and uses thereof
03/10/2005WO2003085089A3 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
03/10/2005WO2003076570A3 Antigens and their use as diagnostics and vaccines against species of plasmodium
03/10/2005WO2003027254A9 15625 receptor, a novel g-protein coupled receptor
03/10/2005WO2003010290A3 Novel class ii cytokine receptors and uses thereof
03/10/2005US20050054845 Thymosin augmentation of genetic immunization
03/10/2005US20050054833 Immunoglobulin fusion for use in treatment and prevention of asthma, food allergies, sinus inflammation and vision defects
03/10/2005US20050054828 Proteins involved in cytoadhesion of plasmodlum falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection
03/10/2005US20050054827 Conotoxin amino acid sequences for use as tool in controlling pain; immunotherapy; mimetics
03/10/2005US20050054825 Osteogenic devices
03/10/2005US20050054820 Expression vector comprising nucleotide sequences coding calreticulin/heat shock protein fusion for use as tool in enhancement and induction of major histocompatibility complex immunological response; immunotherapy; tissue targeted therapy
03/10/2005US20050054726 Vaccine
03/10/2005US20050054602 Oligonucleotides containing activated lymphocytes; antibody therapy; antiallergens; skin disorders
03/10/2005US20050054601 Modified polynucleotides with phosphorothiolate linkage; animal growth regulators; immunomoderators; immunotherapy ; autoimmune disease
03/10/2005US20050054600 Modified protein kinase a-specific oligonucleotides and methods of their use
03/10/2005US20050054594 Methods for particle-assisted polynucleotide immunization using a pulsed electric field
03/10/2005US20050054575 Peptide agonists of prostate-specific antigen and uses therefor
03/10/2005US20050054567 Polypeptides; adjust concentration of stem cells
03/10/2005US20050054107 Replicon particles comprising viral proteins for use in vaccines against viral disease; viricides
03/10/2005US20050054104 Expression vector for use in transfer of heterologous nucleotide sequences into cells expressing FLT3 (FMS-like tyrosine kinase 3); drug delivery; genetic vaccines
03/10/2005US20050054095 For treatment and/or prevention of inflammation and autoimmune disease; vaccines
03/10/2005US20050054075 Attenuated bacteria useful in vaccines
03/10/2005US20050054074 Cell line comprising embryonated poultry cells and attenuated viral particles for use as tool in generation of vaccine for treatment and prevention of in fection by of influenza virus; immunotherapeutics
03/10/2005US20050054052 Therapeutic cytokine for use in prevention and treatment of viral diseases
03/10/2005US20050054038 High level constitutive production of anthrax protective antigen
03/10/2005US20050054036 Growth factor isoform
03/10/2005US20050054019 Human monoclonal antibody for use in the diagnosis prevention and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics
03/10/2005US20050054018 Using cell cycle checkpoint activation modulators to prevent and treat cell proliferative disorders
03/10/2005US20050054016 Determination of bone-sialoprotein in bodily fluids for oncological problems
03/10/2005US20050054007 Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof
03/10/2005US20050053995 Staphylococcus aureus genes and polypeptides
03/10/2005US20050053988 Gene expressed in breast cancer and methods of use
03/10/2005US20050053920 Retrovirus from the HIV group and its use
03/10/2005US20050053919 Using negative-sense single stranded RNA viral sequences as diagnostic tool in detection of respiratory syncytial viral infection
03/10/2005US20050053918 Method of identifying peptides capable of binding to MHC molecules, peptides identified thereby and their uses
03/10/2005US20050053914 Nucleotide sequences coding hepatitis envelope protein for use as tool in detecting hepactocyte receptors; drug screening, viricides and treatment of viral diseases
03/10/2005US20050053667 a hydrogel polymer; an immunogen encapsulated in said hydrogel particle; a ligand on a surface of hydrogel particle, interacts with an antigen presenting cell and providing an activation signal to antigen presenting cell
03/10/2005US20050053666 Antibody-containing particles and compositions
03/10/2005US20050053627 Vaccines for Mycoplasma bovis and methods of use
03/10/2005US20050053626 Using the small pox vaccine to treat genital herpes
03/10/2005US20050053625 Method of treating viral infections
03/10/2005US20050053624 Sequences encoding the pre-membrane and envelope proteins of West Nile virus having an attenuating mutation and the capsid and non-structural proteins of Yellow Fever virus; chimeric flavivirus
03/10/2005US20050053623 Preventing infectious mononucleosis using a vaccine comprising an Epstein-Barr virus (EBV) membrane antigen such as gp350 and adjuvant
03/10/2005US20050053622 Protecting cats against feline infectious peritonitis (FIP); fragments of an S protein of coronavirus
03/10/2005US20050053621 Two live mutant viruses of the same family, wherein contains a mutation in the viral genome at the same genomic site so the mutant viruses cannot recombine with each other to eliminate the mutations; Bovine viral diarrhea virus for example; veterinary medicine
03/10/2005US20050053620 Recombinant vaccinia virus vaccine
03/10/2005US20050053617 Peptides or polypeptides of HCV NS3 protein used to determine antibodies and fusion proteins
03/10/2005US20050053616 peptides based on conserved regions of regulatory and auxiliary HIV proteins, antigens in free or carrier-bound form comprising one of the peptides, vaccine compositions containing one of the antigens, immunoassay kits and a method of detecting antibodies, induced by HIV using such antigens
03/10/2005US20050053615 Variants of mite group 1 allergens for the treatment of house dust mite allergy
03/10/2005US20050053614 Prevention and treatment of amyloidogenic disease
03/10/2005US20050053613 Enhanced immunization and suppression of oral tolerance
03/10/2005US20050053612 Nucleotide regulation of immune responses
03/10/2005US20050053611 Antibody directed enzyme prodrug therapy and a kit with antihumanseminal plasma protein single chain antibodies and prodrugs
03/10/2005US20050053608 Using monoclonal antibody/maytansine fusion as tool in treatment and prevention of cell proliferative disorders; immunotherapy; tissue targeted therapy
03/10/2005US20050053606 MUC1 extracellular domain and cancer treatment compositions and methods derived therefrom
03/10/2005US20050053599 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
03/10/2005US20050053598 Immunoglobulin formulation and method of preparation thereof
03/10/2005US20050053590 Endothelium-targeting nanoparticle for reversing endothelial dysfunction
03/10/2005US20050053579 Conjugates of cytokines, chemokines, and interferons; genetic vaccines; for reducing tumor growth
03/10/2005CA2765058A1 Immunogenic compositions based on microparticles comprising adsorbed toxoid and a polysaccharide-containing antigen
03/10/2005CA2548483A1 Induction of antiviral neutralizing antibodies in humans and animals
03/10/2005CA2542372A1 Method of promoting graft survival with anti-tissue factor antibodies
03/10/2005CA2537928A1 Method of treatment and bioassay involving macrophage migration inhibitory factor (mif) as cardiac-derived myocardial depressant factor
03/10/2005CA2537509A1 Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpopulations and in cryopreservation, culture and transplantation of cells
03/10/2005CA2537161A1 Preventive cancer vaccine based on brother of regulator of imprinted sites molecule (boris)
03/10/2005CA2537140A1 Gastric and prostate cancer associated antigens
03/10/2005CA2537115A1 Methods for the early diagnosis of ovarian cancer
03/10/2005CA2536912A1 Combination therapy for the treatment of ocular neovascular disorders
03/10/2005CA2536911A1 Antibody against nox1 polypeptide, method of diagnosing cancer with the use of nox1 gene and method of screening cancer growth inhibitor
03/10/2005CA2536868A1 Enhancing the circulating half-life of interleukin-2 proteins
03/10/2005CA2536734A1 A rotavirus vaccine
03/10/2005CA2536205A1 Human obesity susceptibility gene and uses thereof
03/10/2005CA2535527A1 Immunogenic hiv compositions and related methods
03/10/2005CA2534579A1 Live attenuated bacterial vaccine
03/10/2005CA2534453A1 Live attenuated aldolase-negative bacterial vaccine
03/10/2005CA2533379A1 Monoclonal antibodies against ricin toxin and methods of making and using thereof
03/10/2005CA2532726A1 Evaluation of adjuvanted vaccines
03/10/2005CA2532335A1 Functional influenza virus-like particles (vlps)
03/10/2005CA2529710A1 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
03/10/2005CA2526128A1 Severe acute respiratory syndrome dna vaccine compositions and methods of use
03/10/2005CA2517396A1 Use of lectins to promote oligomerization of glycoproteins and antigenic molecules
03/09/2005EP1512697A1 TNF Receptor action modulation
03/09/2005EP1512695A1 Hypoallergenic polypeptides based on fish parvalbumin
03/09/2005EP1512694A1 Wasp venom allergens with reduced IgE-reactivity
03/09/2005EP1512693A2 Novel polypeptide, DNA coding for said polypeptide, recombinant vector containing said DNA, recombinant virus prepared using said vector, and use thereof
1 ... 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 ... 1823